Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced the signing of a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing..
Goodbody Health Inc (AQSE: GDBY) has today announced (i) its intention to initiate a normal course issuer bid (“NCIB“) through the facilities of the Canadian Securities Exchange; and (ii) the..
Following on from Poolbeg Pharma plc (LON:POLB) audited results for the period ended 31 December 2021, DirectorsTalk Interviews caught up with Chairman Cathal Friel for his thoughts on the update...
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced the presentation of positive new data from its two lead immunotherapy programmes at the..
Goodbody Health Inc. (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: SCNNF) Scientific Advisory Committee Member Dr Jamie Brosch joins DirectorsTalk Interviews to share his views on the..
Goodbody Health Inc. (AQSE:GDBY) has announced the rollout of its plan to introduce blood testing through its existing network of clinics while it continues to contract with more new pharmacies..
The NHS has announced that it has launched a new lifesaving campaign to encourage people to dial 999 when they are having early signs of a heart attack. With backers..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced it has signed a further commercial contract under its existing master services agreement with a top five global..
Goodbody Health Group Inc (AQSE:GDBY) subsidiary PhytoVista Laboratories Chief Scientific Officer Nick Clarkson caught up with DirectorsTalk for an exclusive interview to discuss the extension of the scope of ISO..
Prediabetes is a serious health condition where blood sugar levels are higher than usual, but not high enough yet for a type 2 diabetes diagnosis. According to Diabetes UK, at..
The Sunday Times reported on the 6 February 2022 that a new blood testing technique due to be introduced by the NHS will determine how likely a patient is to..
We’re on the verge of the biggest shake-up of the UK’s consumer health sector in relation to cannabinoid products (CBD). The Association for the Cannabinoid Industry (ACI) announced in a..
The Board of The National Institute for Health and Care Excellence (NICE), provided an update on 20 January 2022 on how it plans to evaluate promising new health technologies and..
The prostate is a small gland in the pelvis and is part of the male reproductive system. Prostate cancer begins when cells in the prostate gland start to grow out..
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced that the United States Food & Drug Administration (FDA) has cleared the Group’s Investigational..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has provided details of its work plan following the encouraging data..
NHS England has announced that local high street pharmacy will as part of the NHS’s radical action to tackle rising obesity levels and type 2 diabetes offer help to those..
The NHS estimates that more than two in five people in England have high cholesterol which puts them at significant risk of developing heart disease, and around 6.5 million adults..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials announces that further to the..
Following changes to the government’s rules for overseas destinations last week, DirectorsTalk caught up with Marc Howells, CEO of Goodbody Health (AQSE: GDBY) to get his reaction: Marc noted, “Goodbody..
